running because it has 3-4 million in rebates coming after July 1st and with 5 million in the bank already the EV is 8 million while AGN which is combined with a thrombotic to work and not a unique drug like NYR was a 70 million market cap in the same position back in 2021 before GLP and before phase 1. Looking at a testing all time highs in the period ahead
- Forums
- ASX - By Stock
- NYR
- Nyrada Talks PreClinical Success with 180 Markets
Nyrada Talks PreClinical Success with 180 Markets, page-87
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NYR (ASX) to my watchlist
|
|||||
Last
4.6¢ |
Change
0.002(4.55%) |
Mkt cap ! $8.928M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.6¢ | $3.235K | 66.53K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 65305 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 39000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 65305 | 0.045 |
2 | 114404 | 0.044 |
1 | 100000 | 0.042 |
1 | 300000 | 0.041 |
3 | 32500 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 39000 | 1 |
0.054 | 23803 | 1 |
0.055 | 99999 | 1 |
0.056 | 131350 | 2 |
0.057 | 170000 | 2 |
Last trade - 10.57am 05/08/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |